IP Library Granted Patent US 11,590,370
Granted Patent B2
US 11,590,370 · App. 17/081,754 · Granted Feb 28, 2023

Rejuvenating skin by heating tissue for cosmetic treatment of the face and body

Inventors: Peter G. Barthe (Phoenix, AZ); Michael H. Slayton (Phoenix, AZ); Inder Raj S. Makin (Mesa, AZ)
Assignee: Guided Therapy Systems, LLC
A61N7/02A61B5/7405A61B8/08A61B8/0833A61B8/0858A61B8/13A61B8/14A61B8/4209A61B8/4236A61B8/4272A61B8/4281A61B8/4444A61B8/4461A61B8/4483A61B8/4494A61B8/461A61B8/469A61B2090/378A61B2562/046A61N2007/006A61N2007/0008A61N2007/0034A61N2007/0052A61N2007/0065A61N2007/0078A61N2007/0082A61N2007/0095A61N2007/027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,590,370
App. No.
17/081,754
Granted
Feb 28, 2023
Kind
B2
Abstract

Systems and methods for treating skin and subcutaneous tissue with energy such as ultrasound energy are disclosed. In various embodiments, ultrasound energy is applied at a region of interest to affect tissue by cutting, ablating, micro-ablating, coagulating, or otherwise affecting the subcutaneous tissue to conduct numerous procedures that are traditionally done invasively in a non-invasive manner. Lifting sagging tissue on a face, neck, and/or body are described. Treatment with heat is provided in several embodiments.

Claims (30)

1. A method of tightening skin tissue, comprising:

placing an ultrasonic probe on a skin surface over a target tissue;

directing therapeutic ultrasound energy from a piezoelectrically active transduction element of the ultrasonic probe, through the skin surface tissue to the target tissue comprising at least one of the group consisting of: a dermis tissue and a fascia tissue; and

cooling an interface between the ultrasonic probe and the skin surface with a cooling system,

thereby treating at least the fascia tissue in the target tissue at one or more depths under the skin surface to tighten the skin.

2. The method of claim 1 , wherein the directing therapeutic ultrasound energy to the target tissue is for a heating effect.

3. The method of claim 1 ,

wherein the piezoelectrically active transduction element is selected from the group consisting of: a piezoelectric ceramic, lithium niobate, lead titanate, barium titanate, and lead metaniobate.

4. The method of claim 1 , wherein the therapeutic ultrasound energy has a frequency in a range of 3 MHz to 12 MHz.

5. The method of claim 1 , wherein the therapeutic ultrasound energy thermally treats the target tissue to change the appearance of a wrinkle on the skin surface.

6. The method of claim 1 , wherein the therapeutic ultrasound energy is configured for a tissue effect, wherein the tissue effect is one or more of the group consisting of: thermal and non-thermal streaming, cavitational, ablative, and diathermic tissue effects.

7. The method of claim 1 , wherein the ultrasonic probe further comprises an imaging element to image the target tissue at the one or more depths under the skin surface.

8. A method of non-invasive tissue treatment, comprising:

acoustically coupling an ultrasound probe on a skin surface over a region comprising a target tissue comprising a fat tissue and a fascia tissue;

delivering ultrasound energy from at least one piezoelectrically active transduction element to heat the target tissue at one or more depths under the skin surface to treat the at least the fascia tissue in the target tissue, and

cooling an interface between the ultrasound probe and the skin surface with a cooling system.

9. The method of claim 8 , wherein the at least one depth is up to 15 mm under the skin surface.

10. The method of claim 8 , further comprising a pretreatment heating effect that comprises a diffused heating effect.

11. The method of claim 8 , wherein the ultrasound energy thermally treats a wrinkle on the skin surface.

12. The method of claim 8 , wherein the ultrasound energy has a frequency in a range of 3 MHz to 12 MHz.

13. The method of claim 8 , wherein the ultrasound energy has an ablative tissue effect.

14. The method of claim 8 , wherein the ultrasound probe comprises the at least one piezoelectrically active transduction element, wherein the at least one piezoelectrically active transduction element comprises a plurality of piezoelectrically active transduction elements.

15. The method of claim 8 , wherein the piezoelectrically active transduction element is selected from the group consisting of: a piezoelectric ceramic, lithium niobate, lead titanate, barium titanate, and lead metaniobate.

16. The method of claim 8 , further comprising imaging the target tissue under the skin surface with a piezoelectric imaging transduction element in the ultrasound probe electrically connected to a display.

17. A method of non-invasive skin rejuvenation, comprising:

acoustically coupling an ultrasonic probe on a skin surface proximate a region comprising a target tissue comprising at least one of the group consisting of: a dermis tissue and a superficial muscular aponeurotic system (“SMAS”) tissue,

delivering ultrasound energy with a frequency of 3 MHz to 100 MHz from the ultrasonic probe to the target tissue for a heating effect to treat at least the SMAS tissue in the target tissue at a depth under the skin surface to rejuvenate the skin, and

cooling an interface between the ultrasonic probe and the skin surface with a cooling system.

18. The method of claim 17 , wherein delivering the ultrasound energy comprises delivering ultrasound energy from a transduction element in the ultrasound probe, wherein the transduction element comprises a piezoelectrically active material, wherein the ultrasound energy has a frequency in a range of 3 MHz to 12 MHz.

19. The method of claim 17 , wherein the ultrasonic probe comprises a plurality of piezoelectric transduction elements.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: BARTHE, PETER G.; SLAYTON, MICHAEL H.; MAKIN, INDER RAJ S.
To: GUIDED THERAPY SYSTEMS, LLC
Reel/Frame 054195/0666 →
Continuity (16)
Continuation 16409678 · May 10, 2019
Continuation 15862400 · Jan 4, 2018
Continuation 14740092 · Jun 15, 2015
Continuation 13965741 · Aug 13, 2013
Continuation 13835635 · Mar 15, 2013
Continuation 13494856 · Jun 12, 2012
Continuation In Part 12437726 · May 8, 2009
Continuation In Part 12028636 · Feb 8, 2008
Continuation In Part 11857989 · Sep 19, 2007
Continuation In Part 11163148 · Oct 6, 2005
Continuation In Part 11163151 · Oct 6, 2005
Continuation 10950112 · Sep 24, 2004
Provisional Application 60826199 · Sep 19, 2006
Provisional Application 60616755 · Oct 6, 2004
Provisional Application 60616754 · Oct 6, 2004
Related Publication 20210069530A1 · Mar 11, 2021